Home » FDA Advisory Committee to Review Adolor's NDA for Entereg
FDA Advisory Committee to Review Adolor's NDA for Entereg
Adolor Corp. and GlaxoSmithKline said that the Gastrointestinal Drugs Advisory Committee to the FDA will review Adolor's New Drug Application or NDA for Entereg or alvimopan on January 23, 2008.
TradingMarkets
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May